Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | FDPS | P14324 | 2/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27854795 | 1.00 | MEN1 (0.39) | MEN1KMT2AFDPSDPP7SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL27404843 | 0.97 | MEN1 (0.37) | MEN1KMT2AFDPSDPP7SMN1; SMN2 | |
| SCHEMBL841130 | 0.97 | — | — | |
| SCHEMBL3923601 | 0.86 | — | — | |
| SCHEMBL636365 | 0.86 | TSHR (0.37) | MEN1KMT2ATSHR | |
| SCHEMBL22711078 | 0.81 | OPRM1 (0.34) | SMN1; SMN2SLC6A2SLC6A4 | |
| SCHEMBL1650151 | 0.80 | SLC6A3 (0.40) | MEN1KMT2ASLC6A3SLC6A2SLC6A4 | |
| SCHEMBL11543878 | 0.78 | OPRD1 (0.38) | MEN1KMT2ASMN1; SMN2SLC6A2SLC6A4 | |
| SCHEMBL18727479 | 0.78 | ALDH1A1 (0.42) | KMT2ASMN1; SMN2MAPTALDH1A1TSHR | |
| SCHEMBL8767704 | 0.77 | KDM4E (0.35) | ALDH1A1SLC6A3TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119391317-A | Packaging adhesive film for light flexible component and preparation method thereof | 常州斯威克光伏新材料有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-118059905-A | Method for preparing methanol by integrating carbon dioxide trapping and hydrogenation by using Cu-based catalyst | 上海陕煤高新技术研究院有限公司 | 2024-05-24 | — | — | CN | claimed |
| EP-3461552-B1 | CARBON DIOXIDE ABSORBENT AND APPARATUS OF SEPARATING AND RECOVERING CARBON DIOXIDE | TOSHIBA KK (JP) | 2023-12-13 | — | — | EP | claimed |
| CN-116284848-A | Method for dissolving chitosan/cellulose by using multifunctional acidic ionic liquid | 南京工业大学 | 2023-06-23 | — | — | CN | claimed |
| CN-114014825-B | Synthesis method of histamine H3 receptor antagonist telithromycin | 河南师范大学 | 2023-06-02 | — | — | CN | claimed |
| CN-114014825-A | Efficient synthesis method of histamine H3 receptor antagonist teloprolofen | 河南师范大学 | 2022-02-08 | — | — | CN | claimed |
| US-11130858-B2 | Curable compositions for cured-in-place pipes | PIPEFUSION CIPP CORPORATION (US) | 2021-09-28 | — | — | US | claimed |
| US-20210095114-A1 | CURABLE COMPOSITIONS FOR CURED-IN-PLACE PIPES | PIPEFUSION CIPP CORPORATION (US) | 2021-04-01 | — | — | US | claimed |
| US-10865305-B2 | Method of curing a cured-in-place liner | PIPEFUSION CIPP CORPORATION (US) | 2020-12-15 | — | — | US | claimed |
| US-20200291224-A1 | CURABLE COMPOSITION FOR CURED IN PLACE PIPES | PIPEFUSION CIPP CORPORATION (US) | 2020-09-17 | — | — | US | claimed |
| US-20140243456-A1 | Anhydride Accelerators for Epoxy Resin Systems | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-08-28 | — | — | US | claimed |
| EP-2710006-A1 | AZAINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS | Principia Biopharma Inc. (US) | 2014-03-26 | — | — | EP | claimed |
| CN-103435575-A | Preparation method of 1- (3- (3- (4-chlorphenyl) propoxy) propyl) piperidine hydrochloride | INST PHARM & TOXICOLOGY AMMS | 2013-12-11 | — | — | CN | claimed |
| WO-2012158785-A1 | AZAINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS | PRINCIPIA BIOPHARMA INC. (US) | 2012-11-22 | — | — | WO | claimed |
| EP-1963331-A1 | AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS | Exelixis, Inc. (US) | 2008-09-03 | — | — | EP | claimed |
| WO-2007070796-A1 | AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2007-06-21 | — | — | WO | claimed |
| US-20030232739-A1 | Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist | PFIZER INC. | 2003-12-18 | — | — | US | claimed |
| WO-1997009376-A1 | STABILIZATION SYSTEMS FOR POLYMERIC MATERIALS IN PELLET FORM | CIBA SPECIALITY CHEMICALS HOLDING INC. (CH) | 1997-03-13 | — | — | WO | claimed |
| US-RE35217-E | ALKALINE DEVELOPMENT OF EXPOSED NOVOLAK/O-QUINONEDIAZIDE PHOTORESIST LATENT IMAGE | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-23 | — | — | US | claimed |
| US-4264599-A | HYPOTENSIVE AGENTS, ADRENERGIC BLOCKING AGENTS | CIBA-GEIGY CORPORATION (US) | 1981-04-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232739-A1 | Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist | GRIN1, GRIN2B, GRIN2A | MEN1 3545/4885KMT2A 922/4885FDPS 3009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.